Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancer.

M.T. de Bruijn; D.A.E. Raats; J Tol; J.W.J. Hinrichs; S. Teerenstra; C.J.A. Punt; I.H.M. Borel Rinkes; O. Kranenburg

Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancer.

Translated title of the contribution: Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancer.

M.T. de Bruijn, D.A.E. Raats, J Tol, J.W.J. Hinrichs, S. Teerenstra, C.J.A. Punt, I.H.M. Borel Rinkes, O. Kranenburg

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancer.
Original language	Undefined/Unknown
Pages (from-to)	1379-1385
Number of pages	7
Journal	Anticancer Research
Volume	31
Issue number	4
Publication status	Published - 2011

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/21508389

Cite this

@article{d5bd8154bbbc4768bca9eb8f68b9bbeb,

title = "Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancer.",

author = "{de Bruijn}, M.T. and D.A.E. Raats and J Tol and J.W.J. Hinrichs and S. Teerenstra and C.J.A. Punt and {Borel Rinkes}, I.H.M. and O. Kranenburg",

year = "2011",

language = "Undefined/Unknown",

volume = "31",

pages = "1379--1385",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "4",

}

TY - JOUR

T1 - Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancer.

AU - de Bruijn, M.T.

AU - Raats, D.A.E.

AU - Tol, J

AU - Hinrichs, J.W.J.

AU - Teerenstra, S.

AU - Punt, C.J.A.

AU - Borel Rinkes, I.H.M.

AU - Kranenburg, O.

PY - 2011

Y1 - 2011

M3 - Article

SN - 0250-7005

VL - 31

SP - 1379

EP - 1385

JO - Anticancer Research

JF - Anticancer Research

IS - 4

ER -